3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
27
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
5
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
2
Leukemia, Monocytic, Acute
2
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasms
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Basophilic, Acute
1
Hematologic Neoplasms
1
Down Syndrome
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
fludarabine
4
fludarabine phosphate
3
asciminib
3
venetoclax
2
gilteritinib
2
Whole-Body Irradiation
2
Tacrolimus
2
Idarubicin
2
Cytarabine
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
ponatinib
1
nilotinib
1
enasidenib
1
blinatumomab
1
aldesleukin
1
Thiotepa
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Methotrexate
1
Mesna
1
Melphalan
1
Interleukin-2
1
Imatinib Mesylate
1
Hyperbaric Oxygenation
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Daunorubicin
×
90 days
×
Clear all
No trials found.